T. Khelifa et al., EXPRESSION OF TOPOISOMERASE-II-ALPHA AND TOPOISOMERASE-II-BETA IN CHINESE-HAMSTER LUNG-CELLS RESISTANT TO TOPOISOMERASE-II INHIBITORS, Molecular pharmacology, 46(2), 1994, pp. 323-328
Chinese hamster lung cells resistant to 9-OH-ellipticine, i.e., DC-3F/
9-OH-E cells, are several hundredfold resistant to DNA topoisomerase I
I inhibitors. According to previous studies, this resistance is associ
ated with reduced topoisomerase II activity (about 4-fold) and decreas
ed capacity of the topoisomerase II inhibitors to induce stabilization
of the cleavable complex (about 10-fold). In the present work, an ant
ibody was raised against a fragment of human topoisomerase II alpha. T
his antibody, which recognizes both isoforms, was used to determine th
e amounts of topoisomerases II alpha and beta in the sensitive and res
istant cells. Northern and immunoblot analyses showed that (i) in the
parental DC-3F cells the alpha enzyme is about 20-fold more abundant t
han the beta enzyme and the enzyme isoforms undergo reciprocal regulat
ion during the cell growth phases, with the expression of the alpha en
zyme dropping at the plateau phase while the expression of the beta en
zyme increases, and (ii) in the resistant cells the amount of alpha en
zyme is about 4-5-fold smaller than that in the sensitive cells, where
as the beta enzyme is almost undetectable. Analysis of DNA restriction
sites in several independently selected resistant subclones revealed
some rearrangements in the beta gene in two clones. However, these gen
e alterations did not correlate with changes in the resistance level.
The relative contribution of these different changes to the resistance
phenotype is discussed.